ArticleKlinische Monatsblatter fur Augenheilkunde2025
"My First 100 Vitrectomies": Two Years of Collaborative Learning with the Vitreoretinal Fellowship in Switzerland.
Article in Klinische Monatsblatter fur Augenheilkunde, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo evaluate baseline characteristics, intraoperative choices, and surgical outcomes in patients operated by a vitreoretinal (VR) fellow during his first 2 years of fellowship in the Swiss medical system.
settingLongitudinal, monocentric, retrospective study, conducted at the University Hospitals of Geneva.
methodsAll consecutive cases were included that were operated by the same VR fellow at a tertiary university centre between January 2022 and March 2024. The primary outcome was the surgical success after any surgery. Secondary outcomes were the final best-corrected visual acuity (BCVA) at the final follow-up visit as well as adverse events (AEs).
resultsOne-hundred eyes of 89 patients were included (65 men and 24 women, mean age 61.5 ± 16.1 years, range 22 - 94 years). Out of those 100 vitrectomies, 38.0% were operated by the fellow with the supervisor, who was present in the operating theatre but not sitting at the microscope (group A), 36.0% were operated under direct observation by the supervisor who was sitting at the microscope next to the fellow (group B), and in 26.0% of the eyes with the fellow able to do perform only some parts of the surgery based on his expertise at that time, while the rest was completed by the supervisor (group C). The main type of surgery performed was vitrectomy for rhegmatogenous retinal detachment (52.0%; n = 52) followed by silicone oil removal (13.0%), endophthalmitis (8.0%), epiretinal membrane peeling (8.0%), secondary intraocular lens (7.0%), trauma (5.0%), diabetic haemorrhage or tractional retinal detachment (4.0%), macular hole (2.0%), and vitreous haemorrhage (1%). Out of all these, 58.0% of the operations were classified as emergency (mostly rhegmatogenous retinal detachment (RRD), endophthalmitis and trauma), and 42.0% as elective. Eighty-three operations were standalone vitrectomies, while 17 were combined with cataract surgery. In the group undergoing vitrectomy for RRD, the most frequent operation performed, 48.1% of the operations belong to group A, while the rest was split between groups B and C. Forty eyes (79.6%) were classified as recent and uncomplicated RRD, and 12 (23.1%) as long-standing or complicated RRD. Most of the RRD cases were macula-on (59.6%; n = 31) and phakic (69.2%; n = 36). In order to manage RRD, perfluorocarbon liquid was used in 40.4% of the eyes, and retinotomy was performed in 26.9% of the cases. Thirty-four patients (65.4%) required a 360° laser retinopexy and ab-externo cryocoagulation of the retinal tears. The most often used endotamponade for RRD surgery was 14% C3F8 gas (42.3%; n = 22) followed by 20% SF6 gas (26.9%; n = 14), heavy silicone oil (13.5%; n = 7); 1000 cSt silicone oil (9.7%; n = 5), and 5000 cSt silicone oil (3.9%; n = 2). Out of all operations, mean BCVA improved significantly during follow-up (0.32 ± 0.34 decimals at baseline vs. 0.47 ± 0.30 decimals at the final follow-up; p < 0.05). Four eyes (4.0%) were classified as failures and required a subsequent operation, mostly for recurrent RRD. The most frequent AE was post-operative cystoid macular oedema, which occurred in 4.0% of the eyes, and cataract development, which occurred in almost all patients who were phakic at the time of surgery. One patient experienced a lens touch during the surgery for RRD and had developed a white cataract at post-operative follow-up. Average follow-up time was 5.5 ± 5.4 months (range 1 - 24 months).
conclusionsThis study provides a comprehensive analysis of the surgical outcomes and intraoperative experiences of a vitreoretinal fellow during their initial 2-year fellowship in Switzerland. The majority of operations, notably for rhegmatogenous retinal detachment, gave successful outcomes with significant improvements in visual acuity observed post-operatively. The collaborative approach between the fellow and the supervisors varying from direct observation to independent performance showcases a structured training environment. Despite encountering some adverse events, our findings underscore the effectiveness of the fellowship programme in imparting valuable surgical skills and achieving favourable patient outcomes in vitreoretinal surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.